Feb 11 (Reuters) - Zomedica Pharmaceuticals Corp:
* ZOMEDICA FILES U.S. PATENT APPLICATION FOR FECAL PARASITE DETECTION
* ZOMEDICA PHARMACEUTICALS - ASSUMING DEVELOPMENT WORK IS SUCCESSFULLY COMPLETED, CO EXPECTS COMMERCIAL LAUNCH OF ZM-020 FECAL TEST TO OCCUR BY 2022
* ZOMEDICA PHARMACEUTICALS CORP - ASSUMING DEVELOPMENT WORK IS SUCCESSFULLY COMPLETED ZOMEDICA EXPECTS COMMERCIAL LAUNCH OF ZM-020 URINE TESTS BY 2023
* ZOMEDICA PHARMACEUTICALS - CO IS STRATEGICALLY COMMITTED TO A SINGULAR COMMERCIAL FOCUS OF ITS ENDOCRINE DIAGNOSTIC PLATFORM, TRUFORMA THROUGH 2021 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.